| 发明名称 |
Potentiation of therapeutic effects of fatty acids |
| 摘要 |
The oral administration of an essential fatty acid, preferably eicosapentaenoic acid, at a defined purity together with an inhibitor of COX-1 or COX-2 or LOX or one or more of the FACL enzymes gives improved therapeutic results over administration of the fatty acid alone.
|
| 申请公布号 |
US2005209329(A1) |
申请公布日期 |
2005.09.22 |
| 申请号 |
US20050128401 |
申请日期 |
2005.05.13 |
| 申请人 |
LAXDALE LIMITED |
发明人 |
HORROBIN DAVID F. |
| 分类号 |
A61K45/00;A61K31/19;A61K31/20;A61K31/201;A61K31/202;A61K31/405;A61K31/415;A61P1/04;A61P3/00;A61P3/10;A61P5/24;A61P9/10;A61P11/06;A61P13/02;A61P13/04;A61P13/12;A61P15/00;A61P17/04;A61P17/06;A61P19/02;A61P19/10;A61P21/02;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P29/00;A61P35/00;A61P43/00;(IPC1-7):A61K31/202 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
